Skip to content
AiSeekAiSeek
Sign in

Company

MitoCareX Bio

FollowOpen structure mapAsk about thisResearch this company

Description

Headquarters
IL

Structure of MitoCareX Bio

MitoCareX Bio

Company

1 connections
OwnershipInvestment and holdings
Relationship began2026
MitoCareX BioCompany · 1 connections
Layer 1

OwnershipInvestment and holdings1

Relations

Arrows show the direction of the relationship. Filter to focus on a business area.

  • Nexentis Technologies Inc.owns →MitoCareX Bio
    Company · Nexentis Technologies Inc.Evidence 2
    Fact90%
    View evidence
    • CompanyGlobeNewswire public company news2026-10-07 19:32
      Nexentis Technologies Inc. (NASDAQ: NXTS) owns 100% of MitoCareX Bio Ltd, a drug discovery company.
      View source
    • CompanyGlobeNewswire public company news2026-10-07 19:32
      MitoCareX Bio Ltd. (“MitoCareX”), its wholly owned subsidiary
      View source

Showing 1 to 1 of 1

Claims

Read the assertion alongside its sources. Expand a row to inspect the evidence.

FactEvidence 2
ownsNexentis Technologies Inc.

Nexentis Technologies Inc. (NASDAQ: NXTS) owns 100% of MitoCareX Bio Ltd, a drug discovery company.

GlobeNewswire public company news · 2026-10-07 19:32

View evidence
  • CompanyGlobeNewswire public company news2026-10-07 19:32
    Nexentis Technologies Inc. (NASDAQ: NXTS) owns 100% of MitoCareX Bio Ltd, a drug discovery company.
    View source
  • CompanyGlobeNewswire public company news2026-10-07 19:32
    MitoCareX Bio Ltd. (“MitoCareX”), its wholly owned subsidiary
    View source

Showing 1 to 1 of 1

Market and valuation

Valuation data is available on Pro and Research.

Included in Pro

Not available: Company signals · Financials · Filings · Guidance